ArticleFrontiers in medicine2025
Differential diagnosis of pneumoconiosis mass shadows and peripheral lung cancer using CT radiomics and the AdaBoost machine learning model.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of a clinical nomogram for predicting hemorrhagic rupture in renal angiomyolipoma and analysis of molecular correlates (Open medicine (Warsaw, Poland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop a differential diagnostic prediction model for distinguishing large opacities in pneumoconiosis from peripheral lung cancer based on CT radiomics. Methods: A total of 103 cases of large opacities in pneumoconiosis and 85 cases of peripheral lung cancer were retrospectively collected from routine CT scans at the First Affiliated Hospital of Chongqing Medical and Pharmaceutical College between March 2021 and June 2025. Diagnosis was confirmed by an expert panel, clinical evaluations, and pathological examinations. Patients were randomly assigned to a training set ( Results: A total of 108 features were extracted from 110 large opacity regions and 85 peripheral lung cancer regions of interest (ROIs). Dimensionality reduction identified a subset of eight most significant features. LR, SVM, and AdaBoost algorithms were implemented using Python to build the models. In the training set, the accuracies of the LR, SVM, and AdaBoost models were 79.4, 84.0, and 80.9%, respectively; the sensitivities were 74.1, 74.1, and 81.0%, respectively; the specificities were 83.6, 91.8, and 80.8%, respectively; and the AUC values were 0.837, 0.886, and 0.900, respectively. In the test set, the accuracies of the LR, SVM, and AdaBoost models were 80.7, 82.5, and 86.0%, respectively; the sensitivities were 89.3, 89.3, and 82.1%, respectively; the specificities were 72.4, 75.9, and 89.7%, respectively; and the AUC values were 0.825, 0.855, and 0.900, respectively. The AUC of the AdaBoost ROC curve was significantly superior to those of the LR and SVM models. The AdaBoost model demonstrated the optimal predictive performance in both the training and test sets. Conclusion: The AdaBoost-based prediction model, developed using CT radiomic features, effectively differentiates large opacities of stage III occupational pneumoconiosis from peripheral lung cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.